NCT01462162View on ClinicalTrials.gov

A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

122

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Tocilizumab

Trial Locations (16)

15405

A Coruña

17002

Girona

27880

Lugo

30120

El Palmar

30203

Cartagena

30800

Lorca

32005

Ourense

36204

Vigo

43003

Tarragona

43204

Tarragona

08035

Barcelona

08907

Barcelona

08906

L'Hospitalet de Llobregat

08100

Mollet del Vallès

08208

Sabadell

08970

Sant Joan Despí

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01462162 - A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter